Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCVAC/PCa + Hormone Therapy in Metastatic Prostate Cancer
NCT02107391Phase 2Completed
- Sponsor
- SOTIO Biotech
- Start
- Mar 2012
- Primary completion
- Dec 2015
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of stapuldencel in prostate cancer (PCa), sponsored by SOTIO Biotech. Started Mar 2012; status: completed.
02
Drugs
stapuldencel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02107391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107391.